{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:03Z","timestamp":1793608023484,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303894"],"award-info":[{"award-number":["82303894"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82500632"],"award-info":[{"award-number":["82500632"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200564"],"award-info":[{"award-number":["82200564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573945"],"award-info":[{"award-number":["82573945"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170738"],"award-info":[{"award-number":["32170738"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M721408"],"award-info":[{"award-number":["2022M721408"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017527","name":"Jiangsu Cancer Hospital","doi-asserted-by":"publisher","award":["YSZD202405"],"award-info":[{"award-number":["YSZD202405"]}],"id":[{"id":"10.13039\/501100017527","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20220311"],"award-info":[{"award-number":["BK20220311"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20251124"],"award-info":[{"award-number":["BK20251124"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","award":["PY 2023033"],"award-info":[{"award-number":["PY 2023033"]}],"id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004492","name":"National Youth Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.canlet.2026.218446","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:13:59Z","timestamp":1774372439000},"page":"218446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Genome-wide CRISPR\/Cas9 screen identified MCL1 as a senolytic target for clearing palbociclib-induced senescent and PD-L1-positive cells in colorectal cancer"],"prefix":"10.1016","volume":"647","author":[{"given":"Haiyang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suisui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingde","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianghu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhining","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218446_bib1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(24)00360-X","article-title":"Colorectal cancer","volume":"404","author":"Eng","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218446_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13030642","article-title":"Advances in targeted and chemotherapeutic strategies for colorectal cancer: current insights and future directions","volume":"13","author":"Shaham","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.canlet.2026.218446_bib3","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1158\/1078-0432.CCR-15-1185","article-title":"FDA approval: palbociclib for the treatment of postmenopausal patients with Estrogen receptor-positive, HER2-Negative metastatic breast cancer","volume":"21","author":"Beaver","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218446_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrclinonc.2016.26","article-title":"Treating cancer with selective CDK4\/6 inhibitors","volume":"13","author":"O'Leary","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218446_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jcmgh.2022.07.005","article-title":"Additive effect of CD73 inhibitor in colorectal cancer treatment with CDK4\/6 inhibitor through regulation of PD-L1","volume":"14","author":"Noh","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218446_bib6","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1158\/0008-5472.CAN-22-0198","article-title":"Targeting RAS mutant colorectal cancer with dual inhibition of MEK and CDK4\/6","volume":"82","author":"Sorokin","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218446_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccell.2018.03.023","article-title":"CDK4\/6 inhibitors: the mechanism of action may not be as simple as once thought","volume":"34","author":"Klein","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218446_bib8","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1016\/j.molcel.2023.10.016","article-title":"CDK4\/6 inhibitor-mediated cell overgrowth triggers osmotic and replication stress to promote senescence","volume":"83","author":"Crozier","year":"2023","journal-title":"Mol Cell"},{"key":"10.1016\/j.canlet.2026.218446_bib9","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1038\/s41388-020-1354-9","article-title":"Senescence as a therapeutically relevant response to CDK4\/6 inhibitors","volume":"39","author":"Wagner","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218446_bib10","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1158\/1078-0432.CCR-17-2074","article-title":"Therapeutic challenge with a CDK 4\/6 inhibitor induces an RB-Dependent SMAC-mediated apoptotic response in non-small cell lung cancer","volume":"24","author":"Thangavel","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218446_bib11","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.molcel.2024.05.021","article-title":"CDK4 phosphorylates AMPKalpha2 to inhibit its activity and repress fatty acid oxidation","volume":"84","author":"Lopez-Mejia","year":"2024","journal-title":"Mol Cell"},{"key":"10.1016\/j.canlet.2026.218446_bib12","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-19-0708","article-title":"CDK4 regulates lysosomal function and mTORC1 activation to promote cancer cell survival","volume":"79","author":"Martinez-Carreres","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218446_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature25015","article-title":"Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance","volume":"553","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218446_bib14","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1016\/j.celrep.2018.02.053","article-title":"The CDK4\/6 inhibitor abemaciclib induces a T cell inflamed tumor microenvironment and enhances the efficacy of PD-L1 checkpoint blockade","volume":"22","author":"Schaer","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218446_bib15","article-title":"PD-1 blockade and CDK4\/6 inhibition augment nonoverlapping features of T cell activation in cancer","volume":"220","author":"Ali","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2026.218446_bib16","article-title":"Double-Faced immunological effects of CDK4\/6 inhibitors on cancer treatment: challenges and perspectives","volume":"11","author":"Liu","year":"2024","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.canlet.2026.218446_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","article-title":"How the ageing microenvironment influences tumour progression","volume":"20","author":"Fane","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218446_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12943-024-02096-7","article-title":"Cellular senescence and SASP in tumor progression and therapeutic opportunities","volume":"23","author":"Dong","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218446_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","article-title":"Exploiting senescence for the treatment of cancer","volume":"22","author":"Wang","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218446_bib20","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/jnci\/djab064","article-title":"Therapy-Induced senescence: opportunities to improve anticancer therapy","volume":"113","author":"Prasanna","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2026.218446_bib21","doi-asserted-by":"crossref","first-page":"eabb3420","DOI":"10.1126\/science.abb3420","article-title":"p21 produces a bioactive secretome that places stressed cells under immunosurveillance","volume":"374","author":"Sturmlechner","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218446_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101243","article-title":"Mechanisms of abemaciclib, a CDK4\/6 inhibitor, induced apoptotic cell death in prostate cancer cells in vitro","volume":"15","author":"Guney Eskiler","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2026.218446_bib23","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.3390\/curroncol29080462","article-title":"Palbociclib induces the apoptosis of lung squamous cell carcinoma cells via RB-Independent STAT3 phosphorylation","volume":"29","author":"Xiang","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.canlet.2026.218446_bib24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3892\/ol.2021.12864","article-title":"Palbociclib induces cell senescence and apoptosis of gastric cancer cells by inhibiting the Notch pathway","volume":"22","author":"Bi","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2026.218446_bib25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","article-title":"Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens","volume":"568","author":"Behan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218446_bib26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41419-023-06233-w","article-title":"Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218446_bib27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature19830","article-title":"The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models","volume":"538","author":"Kotschy","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218446_bib28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","article-title":"Cleavage of BID by caspase 8 mediates the mitochondrial damage in the fas pathway of apoptosis","volume":"94","author":"Li","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218446_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s43856-023-00380-z","article-title":"Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients","volume":"3","author":"Yuda","year":"2023","journal-title":"Commun. Med."},{"key":"10.1016\/j.canlet.2026.218446_bib30","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1158\/1078-0432.CCR-24-0028","article-title":"A phase 1 first-in-human study of the MCL-1 inhibitor AZD5991 in patients with relapsed\/refractory hematologic malignancies","volume":"30","author":"Desai","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218446_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","article-title":"The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy","volume":"10","author":"Vogler","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218446_bib32","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1158\/1078-0432.CCR-19-1872","article-title":"Dual targeting of CDK4\/6 and BCL2 pathways augments tumor response in Estrogen receptor-positive breast cancer","volume":"26","author":"Whittle","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218446_bib33","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41467-022-29205-8","article-title":"CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity","volume":"13","author":"Joung","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218446_bib34","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41586-022-05388-4","article-title":"Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes","volume":"611","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218446_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/mcb.00171-22","article-title":"Upregulation of PD-L1 in senescence and aging","volume":"42","author":"Onorati","year":"2022","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218446_bib36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00109-024-02444-6","article-title":"The role of the immunosuppressive PD-1\/PD-L1 checkpoint pathway in the aging process and age-related diseases","volume":"102","author":"Salminen","year":"2024","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.canlet.2026.218446_bib37","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/s43018-024-00814-0","article-title":"BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models","volume":"5","author":"Rauh","year":"2024","journal-title":"Nat. Cancer"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:36:58Z","timestamp":1793605018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526002090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"alternative-id":["S0304383526002090"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218446","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genome-wide CRISPR\/Cas9 screen identified MCL1 as a senolytic target for clearing palbociclib-induced senescent and PD-L1-positive cells in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218446"}}